The North American Stem Cell Assay Market size is forecasted to grow USD 733.37 Million by 2025 from USD 297.2 Million in 2020, registering a CAGR of 19.8% between 2020 to 2025.
The growing patient population, rising incidence of chronic diseases, and initiatives by the North American governments for stem cell-based research are primarily accelerating the stem cell assay market in this region. For Instance, in the U.S., 1,735,350 new cancer cases were found as per the National Cancer Institute. Growing demand for stem cell assays, rise in the patient population admitting to the hospitals due to the increasing medical stress are increasing amount spent for the healthcare by people are some of the significant factors driving the growth of the market. An increase in the number of regenerative medicine centers and a growing number of stem cell bank supplements drive the North American stem cell assay market.
High costs associated with the research of stem cells and the behavioral issues of the market are likely to restrict the growth in the region. Scarcity of certified performers, strict administrative rules and schemes for the acceptance of the drug, and a deficit of understanding capacity pertaining to the stem cell assay market hinder the market growth in the region over the forecast period.
This research report on the North American Stem Cell Assay Market has been segmented and sub-segmented into the following categories:
By Assay Type:
By Kits:
By Application:
By End User:
By Country:
Based on region, the USA dominates the North American Stem Cell Assays Market due to a large number of research institutes focusing on stem cell-based research and an increase in investments in the development of regenerative medicine.
The U.S follows the Canadian stem cell assays market in leading the North American region due to the growth in the acquisition of stem cell assays. Research and development activities and a surge in acceptances for clinical trials in stem cell research are necessary to grow successfully.
Noteworthy companies dominating the North America Stem Cell Assay Market Profiled in the Report are Thermo Fisher Scientific Inc., Bio-Techne Corporation, Stem cell Technologies Inc., Merck KGaA, Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Assay Type
5.1.1 Introduction
5.1.2 Cell Viability & Toxicity Assays
5.1.3 Cell Identification Assays
5.1.4 Cell Differentiation Assays
5.1.5 Isolation/Purification Assays
5.1.6 Cell Proliferation Assays
5.1.7 Cell Apoptosis Assays
5.1.8 Cell Function Assays
5.1.9 Y-o-Y Growth Analysis, By Assay Type
5.1.10 Market Attractiveness Analysis, By Assay Type
5.1.11 Market Share Analysis, By Assay Type
5.2 Technology
5.2.1 Introduction
5.2.2 Technology Roadmap
5.2.3 Micro Fabricated Assisted Technology
5.2.3.1 Microfluidics Based Cell Trap Technologies
5.2.4 Technology in Development
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Kits
5.3.1 Introduction
5.3.2 Adult Stem Cell Kits
5.3.2.1 Induced Pluripotent Stem Cell Kits
5.3.2.2 Mesenchymal Stem Cell Kits
5.3.2.3 Neuronal Stem Cells Kits
5.3.2.4 Umbilical Cord Stem Cells
5.3.2.5 Hematopoietic Stem Cell Kits
5.3.3 Human Embryonic Stem Cells Kits
5.3.4 Y-o-Y Growth Analysis, By Kits
5.3.5 Market Attractiveness Analysis, By Kits
5.3.6 Market Share Analysis, By Kits
5.4 Product
5.4.1 Introduction
5.4.2 Instruments
5.4.2.1 Micro Electrode Arrays
5.4.2.2 Cell Imaging Systems
5.4.2.3 Automated Cell Counter
5.4.2.4 Flow Cytometer
5.4.3 Detection Kits
5.4.3.1 Immuno Histochemistry Kits
5.4.4 Y-o-Y Growth Analysis, By Product
5.4.5 Market Attractiveness Analysis, By Product
5.4.6 Market Share Analysis, By Product
5.5 Application
5.5.1 Introduction
5.5.2 Regenerative Medicine & Therapy Development
5.5.2.1 Orthopedic & Musculoskeletal Spine
5.5.2.2 Central Nervous System
5.5.2.3 Dermatology
5.5.2.4 Cardiovascular
5.5.2.5 Diabetes
5.5.2.6 Oncology
5.5.2.7 Others
5.5.3 Drug Discovery and Development
5.5.4 Clinical Research
5.6 End User
5.6.1 Introduction
5.6.2 Research Institutes
5.6.3 Industry Research
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Assay Type
6.1.3.3 By Technology
6.1.3.4 By Kits
6.1.3.5 By Product
6.1.3.6 By Application
6.1.3.7 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Assay Type
6.1.4.3 By Technology
6.1.4.4 By Kits
6.1.4.5 By Product
6.1.4.6 By Application
6.1.4.7 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Assay Type
6.1.5.3 By Technology
6.1.5.4 By Kits
6.1.5.5 By Product
6.1.5.6 By Application
6.1.5.7 By End User
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Techne Corporation
8.3 STEMCELL Technologies Inc.
8.4 Promega Corporation
8.5 GE Healthcare
8.6 Bio-Rad Laboratories, Inc.
8.7 Merck KGaA
8.8 Cellular Dynamics International Inc.
8.9 Hemogenix
8.10 Cell Biolabs Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
